These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2441694)

  • 21. Recent developments in the diagnosis and monitoring of HBV infection and role of the genetic variability of the S gene.
    Weber B
    Expert Rev Mol Diagn; 2005 Jan; 5(1):75-91. PubMed ID: 15723594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1.
    Maeng CY; Ryu CJ; Gripon P; Guguen-Guillouzo C; Hong HJ
    Virology; 2000 Apr; 270(1):9-16. PubMed ID: 10772975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Determination of hepatitis B surface antigen subtypes].
    Takaki A; Tatsukawa M; Shiratori Y
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():149-52. PubMed ID: 15453305
    [No Abstract]   [Full Text] [Related]  

  • 24. Serotypic antigenic structure and immunological activity of the synthetic peptide vaccine for hepatitis-B.
    Zheng J; Hu PS; Xu LG; Liu ZP; Huang WT
    Biopolymers; 1986; 25 Suppl():S201-8. PubMed ID: 2430635
    [No Abstract]   [Full Text] [Related]  

  • 25. High immunogenicity of a hydrophilic component of the hepatitis B virus preS1 sequence exposed on the surface of three virus-like particle carriers.
    Skrastina D; Bulavaite A; Sominskaya I; Kovalevska L; Ose V; Priede D; Pumpens P; Sasnauskas K
    Vaccine; 2008 Apr; 26(16):1972-81. PubMed ID: 18343539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Synthesis and expression of the DNA fragment coding the antigenic determinant of the surface antigen protein of hepatitis B virus].
    Smirnov VD; Sergienko OV; Skripkin EA; Dubichev AG; Lunin VG
    Bioorg Khim; 1983 Oct; 9(10):1388-94. PubMed ID: 6207838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mimotope of pre-S2 region of surface antigen of viral hepatitis B screened by phage display.
    Zhang WY; Wan Y; Li DG; Tang Y; Zhou W
    Cell Res; 2001 Sep; 11(3):203-8. PubMed ID: 11642405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and characterization of a C(K/R)TC motif as a common epitope present in all subtypes of hepatitis B surface antigen.
    Qiu X; Schroeder P; Bridon D
    J Immunol; 1996 May; 156(9):3350-6. PubMed ID: 8617960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. De novo infection in a renal transplant recipient caused by novel mutants of hepatitis B virus despite the presence of protective anti-hepatitis B surface antibody.
    Lu M; Lorentz T
    J Infect Dis; 2003 Apr; 187(8):1323-6. PubMed ID: 12696014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viral and clinical factors associated with surface gene variants among hepatitis B virus carriers.
    Roque-Afonso AM; Férey MP; Ly TD; Graube A; Costa-Faria L; Samuel D; Dussaix E
    Antivir Ther; 2007; 12(8):1255-63. PubMed ID: 18240865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A common human anti-hepatitis B surface antigen idiotype is associated with the group a conformation-dependent antigenic determinant.
    Kennedy RC; Sanchez Y; Ionescu-Matiu I; Melnick JL; Dreesman GR
    Virology; 1982 Oct; 122(1):219-21. PubMed ID: 6182686
    [No Abstract]   [Full Text] [Related]  

  • 33. Molecular cartography of globular proteins with application to antigenic sites.
    Fanning DW; Smith JA; Rose GD
    Biopolymers; 1986 May; 25(5):863-83. PubMed ID: 2424521
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms.
    Ho JK; Jeevan-Raj B; Netter HJ
    Viruses; 2020 Jan; 12(2):. PubMed ID: 31973017
    [No Abstract]   [Full Text] [Related]  

  • 35. Bacterial superglue generates a full-length circumsporozoite protein virus-like particle vaccine capable of inducing high and durable antibody responses.
    Janitzek CM; Matondo S; Thrane S; Nielsen MA; Kavishe R; Mwakalinga SB; Theander TG; Salanti A; Sander AF
    Malar J; 2016 Nov; 15(1):545. PubMed ID: 27825348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral treatment of chronic hepatitis B virus (HBV) infections.
    De Clercq E; Férir G; Kaptein S; Neyts J
    Viruses; 2010 Jun; 2(6):1279-1305. PubMed ID: 21994680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine.
    Makidon PE; Bielinska AU; Nigavekar SS; Janczak KW; Knowlton J; Scott AJ; Mank N; Cao Z; Rathinavelu S; Beer MR; Wilkinson JE; Blanco LP; Landers JJ; Baker JR
    PLoS One; 2008 Aug; 3(8):e2954. PubMed ID: 18698426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Aspergillus niger as host for virus-like particle production, using the hepatitis B surface antigen as a model.
    Plüddemann A; Van Zyl WH
    Curr Genet; 2003 Sep; 43(6):439-46. PubMed ID: 12802503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual topology of the large envelope protein of duck hepatitis B virus: determinants preventing pre-S translocation and glycosylation.
    Swameye I; Schaller H
    J Virol; 1997 Dec; 71(12):9434-41. PubMed ID: 9371604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apical sorting of hepatitis B surface antigen (HBsAg) is independent of N-glycosylation and glycosylphosphatidylinositol-anchored protein segregation.
    Marzolo MP; Bull P; González A
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1834-9. PubMed ID: 9050865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.